Related Articles

Brand Name Analysis
Drug Experts
Drug Labeling 1
Drug Labeling 2
Drug Labeling 3
Drug Labeling 4
Drug Name Review
Drug Packaging
Drug Packaging 2
Drug Safety
Drug Safety 2
Effect Analysis
FDA Report
FMEA
FMEA
Generic Drugs
Health Canada Report
Health Canada Report
Look Alike
Medication Safety
Medication Error
Medication Error
Post-marketing Risk Assessment
Risk Minimization
Safe Medication Practices
Stigmatized Diseases

More Articles

 

Health Canada report looks at painkiller prescriptions in Atlantic Canada

Although it was Newfoundland and Nova Scotia that first raised alarms about the abuse of so-called "hillbilly heroin" in Atlantic Canada, it is New Brunswick that accounts for most of the prescriptions for the highly addictive painkiller oxycodone, according to a new Health Canada report.

During the first six months of 2005, more than 92,500 prescriptions were filled for oxycodone-based painkillers, such as OxyContin, at 651 retail pharmacies throughout the four Atlantic provinces.

New Brunswick generated 44 per cent of those transactions, and had the highest number of oxycodone prescribers in the region at 133 per 100,000 residents.

"It's interesting," said Enid Harrison, spokeswoman for the Ottawa-based Canadian Centre on Substance Abuse. "They weren't identifying it as a problem in their province, specifically."

Prince Edward Island accounted for only nine per cent of prescriptions, but the region's least-populous province had the second-highest number of prescribers per capita, with 128 per 100,000 residents.

And prescription users in Prince Edward Island also had the highest volume of transactions, averaging 46 each. New Brunswick prescribers averaged 41 each.

Newfoundland and Labrador and Nova Scotia, where the issue made headlines after several deaths were blamed on oxycodone abuse, accounted for 21 per cent and 27 per cent of the transactions, respectively.
Newfoundland had 114 prescribers per 100,000 residents; Nova Scotia the least of all four Atlantic provinces, with 111.
Nova Scotia also had the lowest average number of transactions per prescriber, at 24. But Harrison and Health Canada warned that the study offers only baseline data, which means it's difficult to draw conclusions.

"Even if we knew across the country how many prescriptions are being doled out, it doesn't tell us how many are being used inappropriately," Harrison said.

The Health Canada report points out that the results don't take into account provincial health profiles, demographics or variances in pain management protocol or products. "Readers who wish to interpret, extrapolate or benchmark the report's findings should exercise caution," it says.

"The outcome of this review of sales transactions cannot be used on its own to determine definitive actions. Its purpose was to provide stakeholders with factual information to contribute to their efforts." Information on oxycodone prescriptions is not readily available from other regions for comparison. "This is the first (such report) we've done at Health Canada," said Carolyn Sexauer, spokeswoman for the department. She said the report was done in response to requests from task forces in Newfoundland and Nova Scotia, adding that Health Canada has other initiatives underway, including a guide for health professionals.

Harrison lauded the Health Canada report for providing a baseline for Atlantic Canada, but there is no consistent monitoring program across the country. "We're looking for it to actually go beyond that, to a much more sophisticated model for monitoring the use of pharmaceutical drugs."


  Related Links

  - FDA
  - FDA MedWatch
  - FDA (AERS)
  - USP
  - Health Canada
  - EMEA
  - NCC MERP
 

   
 
     
     
  Home  |  About Us  |  Proprietary Naming  |  NonProprietary Naming  |  Labeling & Packaging  |  Risk Management  |   News  |  Contact Us
  Copyright © 2005 Drug Safety Institute. All Rights Reserved.